1. World Tuberculosis Day 2013
TB situation in 2011: Findings from the ECDC and WHO/EURO joint TB surveillance report
ECDC TB Team European Centre for Disease Prevention and Control
Stockholm, 24 March 2013

2. TB notification rates in EU/EEA, 2011
In the EU/EEA, TB cases were reported in Notification rate 14.2 per population (range 2.8 – 89.7).
Figure 1: Country-specific TB notification rates, 2011
< 10 per
10 to 19 per
20 to 49 per
50 to 99 per
Not included or not reporting

3. TB notification rates in EU/EEA, 2007−2011
Overall in the EU/EEA, notification rates have steadily declined.
Figure 2: Trend in TB notification rate in the EU/EEA 2007−2011

4. Proportion of confirmed* TB cases in the EU/EEA, 2011
Overall 61.3% (range 27.9 – 94.8%) of TB cases reported in the EU/EEA were laboratory-confirmed.
Figure 3: Country-specific proportion of all confirmed TB cases in 2011.
< 60%
60 to 69%
70 to 79%
≥ 80%
Not included or not reporting
*Confirmed by culture or both a positive sputum microscopy result and Mycobacterium tuberculosis nucleic acid identified in nucleic acid amplification test.

5. TB notification rates in children <15 years of age in EU/EEA, 2011
In 2011, cases of TB in children were reported, accounting for 4.4% of all notified TB cases (range 0 – 11.1%) in the EU/EEA.
Figure 4: Country-specific childhood TB notification rates among child population (0–14 years), 2011
< 2 per child population
2 to 3.9 per child population
4 to 9.9 per child population
≥ 10 per child population
Not included or not reporting

6. Proportion of foreign origin among notified TB cases in EU/EEA, 2011
In 2011, the overall proportion of TB cases of foreign origin in the EU/EEA was 25.8% (range 0.3 – 89.4%).
Figure 5: Country-specific proportion of foreign origin cases among all notified TB cases, EU/EEA, 2011
25 to 49%
≥ 75%
1 to 24%
50 to 74%
< 1%
Not included or not reporting

7. Proportion of notified extrapulmonary TB cases in EU/EEA, 2011
In 2011, the overall proportion of extrapulmonary TB cases in the EU/EEA was 22.3% (range 3.9 – 66.7%).
Figure 6: Country-specific proportion of extrapulmonary TB of all notified TB cases, EU/EEA, 2011
20 to 29%
≥ 50%
5 to 19%
30 to 49%
< 5%
Not included or not reporting

8. Extrapulmonary TB notification rates in EU/EEA, 2002−2011
Extrapulmonary TB notification rates have remained stable in the last 10 years.
Figure 7: Trend in extrapulmonary TB notification rate in the EU/EEA, 2002−2011

9. Proportions of TB by site among all notified TB cases in EU/EEA, 2002−2011
Percentage of extrapulmonary TB increased from 16.4% in 2002 to 22.4% in 2011.
Figure 8: Proportion of notified pulmonary and extrapulmonary TB cases in the EU/EEA, 2002−2011

10. Proportion of culture-confirmed new pulmonary TB cases in EU/EEA, 2011
69% of new pulmonary TB cases were culture-confirmed. The proportion varied widely across countries (range 0 – 98%).
Figure 9: Proportion of new pulmonary TB cases confirmed by culture, 2011

11. Proportion of notified TB cases with multi-drug resistance among all confirmed TB cases in EU/EEA, 2011
In 2011, the overall proportion of TB cases with multi-drug resistance in the EU/EEA was 4.5% (range 0 – 29.8%).
Figure 10: Country-specific proportion of multidrug resistance among all confirmed TB cases,
EU/EEA, 2011
2 to 4.9%
≥ 10%
1 to 1.9%
5 to 9.9%
< 1%
Not included or not reporting

12. Proportion of notified new TB cases with multidrug resistance in EU/EEA, 2011
In 2011, the overall proportion of new TB cases with multi-drug resistance in the EU/EEA was 2.4% (range 0 – 23.3%).
Figure 11: Country-specific proportion of new TB cases with multidrug resistance, EU/EEA,
2 to 4.9%
≥ 10%
1 to 1.9%
5 to 9.9%
< 1%
Not included or not reporting

13. Notification rates of new cases with multidrug resistant TB in EU/EEA, 2007−2011
The notification rate of multidrug resistant TB have remained stable at around 0.3 per population.
Figure 12: Trends in multidrug resistant TB notification rate in the EU/EEA, 2007−2011

14. Proportion of notified previously treated TB cases with multidrug resistance in EU/EEA, 2011
In 2011, the overall proportion of previously treated TB cases with multidrug resistance in the EU/EEA was 16.8% (range 0 – 57.7%).
Figure 13: Country-specific proportion of previously treated TB cases with multi-drug resistance, EU/EEA, 2011
2 to 4.9%
≥ 10%
1 to 1.9%
5 to 9.9%
< 1%
Not included or not reporting

15. Proportion of TB cases with extensive drug resistance among MDR-TB cases with SLD ST* reported in EU/EEA, 2011
In 2011, the proportion of extensive drug resistant cases among cases with multidrug resistance in EU/EEA was 13.4% (range 0 – 40.0%).
Figure 14: Country-specific proportion of extensively drug resistant TB cases among TB cases with multi-drug
resistance, EU/EEA, 2011
5 to 9%
≥ 20%
1 to 4%
10 to 19%
< 1%
Not included or not reporting
Not included or not reporting
*SLD ST – second line drug susceptibility testing result

16. Proportion of HIV positive TB cases among all TB cases with known HIV status in EU/EEA, 2011
In 2011, the overall proportion of HIV positive TB cases among TB cases with known HIV status in EU/EEA was 4.7% (range 0 – 40%).
Figure 15: Country-specific proportion of HIV positive TB cases among TB cases with known HIV status, EU/EEA,
2 to 4.9%
≥ 10%
1 to 1.9%
5 to 9.9%
< 1%
Not included or not reporting

17. Treatment success rate for new pulmonary TB cases in EU/EEA*, 2010
The treatment success rate for new culture-confirmed pulmonary TB cases notified in 2010 was 76.8% (range: 0 – 91.4%).
Figure 16: Treatment success rate for new culture-confirmed pulmonary TB cases notified in 2010
* Five EU/EEA Member States did not report treatment outcome data.

18. Treatment success rate for new pulmonary TB cases by year of reporting in EU/EEA, 2006−2010
The treatment success rate for new culture-confirmed pulmonary TB cases notified between 2006 and 2010 has slightly decreased from 79.5% in 2006 to 76.8% in 2010.
Figure 17: Treatment success rate for new culture-confirmed pulmonary TB cases notified in 2006−2010

19. Treatment success rate for previously treated pulmonary TB cases in EU/EEA*, 2010
The treatment success rate for previously treated culture-confirmed pulmonary TB cases notified in 2010 was 53.7% (range 31.4 – 85.7%).
Figure 18: Treatment success rate for previously treated culture-confirmed pulmonary TB cases notified in 2010
* Iceland and Luxembourg reported zero previously treated TB cases in Seven EU/EEA Member States did not report stratified treatment outcome data

20. Treatment success rate for all notified pulmonary TB cases in EU/EEA
The treatment success rate for all confirmed pulmonary TB cases notified in 2010 was 72.4% (range 0 – 88.9%).
Figure 19: Treatment success rate for all confirmed pulmonary TB cases notified in 2010
* Five EU/EEA Member States did not report treatment outcome data

21. Treatment success* rate for extrapulmonary TB cases in EU/EEA**, 2010
The treatment success rate for extrapulmonary TB cases notified in 2010 was 82.2% (range 21.1 – 100%).
Figure 20: Treatment success rate for extrapulmonary TB cases notified in 2010
*Treatment success of extrapulmonary TB consists of cases reported as completed full course of anti-tuberculosis treatment
** Seven Member States did not report stratified treatment outcome data

22. Treatment success rate for notified multidrug-resistant TB cases in EU/EEA*, 2009
The treatment success rate for all confirmed multidrug-resistant TB cases notified in 2009 was 31.6% (range 0 – 84.6%).
Figure 21: Treatment success rate for all confirmed multidrug-resistant TB cases notified in 2009
* Malta reported zero MDR TB cases in 2009, 11 Member States did not report treatment outcome data

23. Treatment outcome for multidrug-resistant TB cases notified in 2007−2009
Treatment outcomes for multidrug-resistant TB cases did not improve between the 2007 and 2009 cohort, EU/EEA.
Figure 22: Treatment outcome at 24 months for multidrug-resistant TB cases diagnosed in 2009, compared with cases diagnosed in 2007 and 2008